These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 810025)

  • 41. 15 (S)-15-methyl-prostaglandin F2alpha: myometrial response and abortifacient efficacy.
    Wiqvist N; Béguin F; Bygdeman M; Toppozada M
    Adv Biosci; 1973; 9():831-42. PubMed ID: 4805896
    [No Abstract]   [Full Text] [Related]  

  • 42. The use of prostaglandins and their analogues for abortion.
    Bygdeman M
    Clin Obstet Gynaecol; 1984 Dec; 11(3):573-84. PubMed ID: 6391777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Administration of prostaglandins by various routes for induction of abortion. Merits and demerits.
    Krishna U; Ganguli AC; Mandlekar AV; Purandare VN
    Prostaglandins; 1978 Apr; 15(4):685-93. PubMed ID: 674699
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of 15-methyl-prostaglandin F2 alpha used for dilating the cervix uteri before abortion on endogenous prostaglandin F2 alpha synthesis].
    Goncharova VN; Morozova MS; Razina LG; Manuilova IA; Murashko LE
    Akush Ginekol (Mosk); 1981 Dec; (12):37-8. PubMed ID: 6950671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a vaginal suppository suitable for single administration for interruption of second trimester pregnancy.
    Bygdeman M; Ganguli A; Kinoshita K; Lundström V; Green K; Bergström S
    Contraception; 1977 Feb; 15(2):129-41. PubMed ID: 837687
    [No Abstract]   [Full Text] [Related]  

  • 46. Termination of second trimester pregnancy with intra-amniotic 15 (S) 15 methyl prostaglandin F-2alpha - a two dose schedule study.
    Karim SM; Sivasamboo R
    Prostaglandins; 1975 Mar; 9(3):487-94. PubMed ID: 1138305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostaglandin E and F2 alpha levels in plasma and amniotic fluid during mid-trimester abortion induced by trichosanthin.
    Wang YF; Zhou WD; Liu JX; Fi C; Zhu WX; Chen YZ; Yan LM; Shen GS; Wu YE; Zhu W
    Prostaglandins; 1981 Aug; 22(2):289-94. PubMed ID: 6945634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous prostaglandin-F 2 infusion for middle-trimester abortion.
    Lauersen NH; Wilson KH
    Lancet; 1973 May; 1(7813):1195. PubMed ID: 4123590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
    Karim SM; Choo HT; Cheng P
    Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
    Bygdeman M; Christensen N; Gréen K; Lundström V
    Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and acceptability of 15(S)-15-methyl-prostaglandin E2-methyl ester for midtrimester pregnancy termination.
    Bieniarz J; Hunter G; Scommegna A
    Am J Obstet Gynecol; 1974 Nov; 120(6):840-3. PubMed ID: 4429095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cervical dilatation in late first trimester termination by prostaglandin, hylase and isogel.
    Mandlekar AV; Ganguli AC; Krishna UR; Purandare VN
    Prostaglandins Med; 1981 Apr; 6(4):381-7. PubMed ID: 7025067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vaginally administered PGF2alpha for cervical dilatation in nulliparas prior to suction curettage.
    Brenner WE; Dingfelder JR; Staurovsky LG; Hendricks CH
    Prostaglandins; 1973 Dec; 4(6):819-36. PubMed ID: 4783581
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Letter: intrauterine prostaglandins for outpatient termination of very early pregnancy.
    Karim SM
    Lancet; 1973 Oct; 2(7832):794. PubMed ID: 4126492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single dose extra-amniotic prostaglandin gel for midtrimester termination of pregnancy.
    Quinn MA; Shekleton PA; Wein R; Kloss M
    Aust N Z J Obstet Gynaecol; 1980 May; 20(2):77-9. PubMed ID: 6932206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-invasive methods for termination of second trimester pregnancy.
    Bygdeman M
    Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):351-9. PubMed ID: 2225604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interruption of first trimester pregnancy by prostaglandins.
    Bygdeman M; Green K; Lundström V
    Int J Gynaecol Obstet; 1977; 15(1):69-72. PubMed ID: 923898
    [No Abstract]   [Full Text] [Related]  

  • 58. Prostaglandins: current therapeutic status in obstetrics.
    Liggins GC
    Drugs; 1974; 8(3):161-3. PubMed ID: 4434869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Uterine contractility during pregnancy and the effect of abortifacient drugs.
    Bygdeman M; Swahn ML
    Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):249-61. PubMed ID: 2225598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostaglandin analogues and uterotonic potency: a comparative study of seven compounds.
    Wiqvist N; Martin JN; Bygdeman M; Green K
    Prostaglandins; 1975 Feb; 9(2):255-69. PubMed ID: 1135438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.